Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Título:

Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Autor:

Fabiana Resende Rodrigues

Ano:

2021

DOI:

10.3389/fonc.2021.636716

Revista:

Frontiers in Oncology

ISSN:

2234943X

Tags:

Infiltrating Lymphocyte

Neoadjuvant Chemotherapy

Triple-Negative

Home:

[http://https://www.frontiersin.org/articles/10.3389/fonc.2021.636716/full][doi:10.3389/fonc.2021.636716]

Idioma:

Português

Buscar essa publicação no Google Acadêmico

Publicações com a mesma autoria

Does the sequence of anthracycline and taxane matter? The NeoSAMBA trial.

O Possível Envolvimento do HPV no Câncer de Mama

Percepção de pacientes com carcinoma infiltrante de mama a respeito da crioterapia

A Large Vaginal Bulge Might Not Be a Genital Prolapse

COX-2 Expression in Breast Cancer and Impact on Survival Outcomes

Traço falcêmico como apresentação clínica de insuficiência hepática aguda

Oncological Safety of Pectoralis Fascia Preservation in Modified Radical Mastectomies

O decréscimo vertiginoso das autópsias em um hospital universitário do Brasil nos últimos 20 anos

Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment

Mastectomy in the era of implant-based reconstruction: Should we be removing the pectoralis fascia?